• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Women and HIV in Sub-Saharan Africa.撒哈拉以南非洲的妇女与艾滋病病毒。
AIDS Res Ther. 2013 Dec 13;10(1):30. doi: 10.1186/1742-6405-10-30.
2
Tuberculosis结核病
3
AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention.撒哈拉以南非洲地区的艾滋病:异性传播流行病学及预防前景
Epidemiology. 1993 Jan;4(1):63-72.
4
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities.撒哈拉以南非洲地区的艾滋病毒感染与艾滋病:现状、挑战与机遇
Open AIDS J. 2016 Apr 8;10:34-48. doi: 10.2174/1874613601610010034. eCollection 2016.
5
[Current status of the female condom in Africa].[非洲女用避孕套的现状]
Sante. 1997 Nov-Dec;7(6):405-15.
6
Factors Driving the HIV Epidemic in Southern Africa.推动南部非洲艾滋病流行的因素。
Curr HIV/AIDS Rep. 2016 Jun;13(3):158-69. doi: 10.1007/s11904-016-0314-z.
7
The spread and effect of HIV-1 infection in sub-Saharan Africa.人类免疫缺陷病毒1型(HIV-1)感染在撒哈拉以南非洲地区的传播及影响。
Lancet. 2002 Jun 8;359(9322):2011-7. doi: 10.1016/S0140-6736(02)08823-2.
8
HIV in adolescents in sub-Saharan Africa.撒哈拉以南非洲地区青少年中的艾滋病毒。
Curr Opin HIV AIDS. 2009 Jul;4(4):288-93. doi: 10.1097/COH.0b013e32832c7d10.
9
Reproductive health and AIDS prevention in sub-Saharan Africa: the case for increased male participation.撒哈拉以南非洲地区的生殖健康与艾滋病预防:提高男性参与度的必要性
Health Policy Plan. 1996 Mar;11(1):84-92. doi: 10.1093/heapol/11.1.84.
10
Women's rights and women's health during HIV/AIDS epidemics: the experience of women in sub-Saharan Africa.艾滋病毒/艾滋病流行期间的妇女权利与妇女健康:撒哈拉以南非洲地区妇女的经历
Health Care Women Int. 2009 Aug;30(8):690-706. doi: 10.1080/07399330903018377.

引用本文的文献

1
Uptake and factors associated with HIV self-testing among women in South Africa.南非女性中艾滋病病毒自我检测的接受情况及相关因素
J Coll Med S Afr. 2024 May 10;2(1):21. doi: 10.4102/jcmsa.v2i1.21. eCollection 2024.
2
Human immunodeficiency virus vulnerability and pre-exposure prophylaxis awareness among adolescent girls and young women in Cameroon: A cross-sectional study.喀麦隆少女和年轻女性中的人类免疫缺陷病毒易感性及暴露前预防知晓情况:一项横断面研究。
Interdiscip Nurs Res. 2025 Mar;4(1):23-30. doi: 10.1097/nr9.0000000000000086. Epub 2025 Mar 21.
3
A geo-additive spatial analysis of condom use among women aged 15-49 in Rwanda.卢旺达15至49岁女性避孕套使用情况的地理加性空间分析。
Front Public Health. 2025 Jul 31;13:1635694. doi: 10.3389/fpubh.2025.1635694. eCollection 2025.
4
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans.长效卡博特韦加rilpivirine在南非人群中的96周疗效及药代动力学研究
South Afr J HIV Med. 2025 Jul 22;26(1):1709. doi: 10.4102/sajhivmed.v26i1.1709. eCollection 2025.
5
Risk factors associated with HIV infection in four large Brazilian blood centers: A multicentric case-control study (2009-2017).巴西四个大型血液中心与艾滋病毒感染相关的风险因素:一项多中心病例对照研究(2009 - 2017年)
Hematol Transfus Cell Ther. 2025 Jul 4;47(3):103863. doi: 10.1016/j.htct.2025.103863.
6
Estimated impact of long-acting injectable PrEP in South Africa: a model comparison analysis.长效注射用暴露前预防药物在南非的估计影响:模型比较分析
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26453. doi: 10.1002/jia2.26453.
7
Tackling the Triple Threat in Kenya: Factors Associated with Protection against HIV Risk, Gender-Based Violence, and Pregnancy among Adolescent Girls and Young Women.应对肯尼亚的三重威胁:与青春期女孩和年轻女性预防艾滋病毒风险、性别暴力及怀孕相关的因素
AIDS Behav. 2025 Jun;29(6):1738-1746. doi: 10.1007/s10461-025-04643-9. Epub 2025 Feb 13.
8
An Open Letter on Advancing HIV prevention: Augmenting an ecosystem-based approach to understand prevention decision-making.关于推进艾滋病预防的公开信:强化基于生态系统的方法以理解预防决策
Gates Open Res. 2025 Jan 13;8:73. doi: 10.12688/gatesopenres.16067.2. eCollection 2024.
9
Acceptability and feasibility of a urine-based tenofovir adherence assay for monitoring and providing feedback on PrEP adherence in Kenya.一种基于尿液的替诺福韦依从性检测方法在肯尼亚用于监测和提供关于暴露前预防(PrEP)依从性反馈的可接受性和可行性。
AIDS Care. 2025 Feb;37(2):324-336. doi: 10.1080/09540121.2024.2444556. Epub 2024 Dec 28.
10
Energy and vulnerability: Exploring the energy poverty-risky sexual behavior nexus among young women in Ghana.能源与脆弱性:探索加纳年轻女性中能源贫困与危险性行为之间的联系。
SSM Popul Health. 2024 Jan 2;25:101597. doi: 10.1016/j.ssmph.2023.101597. eCollection 2024 Mar.

本文引用的文献

1
Geographical clustering of high risk sexual behaviors in "hot-spots" for HIV and sexually transmitted infections in Kwazulu-Natal, South Africa.南非夸祖鲁-纳塔尔省艾滋病毒和性传播感染“热点”地区高危性行为的地理聚集性。
AIDS Behav. 2014 Feb;18(2):317-22. doi: 10.1007/s10461-013-0578-x.
2
HIV due to female sex work: regional and global estimates.女性性工作者导致的 HIV:区域和全球估计数。
PLoS One. 2013 May 23;8(5):e63476. doi: 10.1371/journal.pone.0063476. Print 2013.
3
Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa.南非德班人群中激素避孕对女性感染 HIV 病毒和妊娠的影响。
Bull World Health Organ. 2012 Oct 1;90(10):748-55. doi: 10.2471/BLT.12.105700. Epub 2012 Jul 16.
4
Preexposure prophylaxis for HIV infection among African women.预防非洲女性感染 HIV 的暴露前预防措施。
N Engl J Med. 2012 Aug 2;367(5):411-22. doi: 10.1056/NEJMoa1202614. Epub 2012 Jul 11.
5
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.抗逆转录病毒预防治疗用于异性恋男性和女性的 HIV 预防。
N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.
6
Assessing and evaluating the combined impact of behavioural and biological risk factors for HIV seroconversion in a cohort of South African women.评估和评价南非女性队列中行为和生物学危险因素对艾滋病毒血清转化的综合影响。
AIDS Care. 2012;24(9):1155-62. doi: 10.1080/09540121.2012.687820. Epub 2012 Jun 18.
7
The relationship between age of coital debut and HIV seroprevalence among women in Durban, South Africa: a cohort study.南非德班女性首次性交年龄与艾滋病毒血清流行率之间的关系:一项队列研究。
BMJ Open. 2012 Jan 5;2(1):e000285. doi: 10.1136/bmjopen-2011-000285. Print 2012.
8
The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections.注射用激素避孕药对 HIV 血清转化和性传播感染的影响。
AIDS. 2012 Jan 28;26(3):375-80. doi: 10.1097/QAD.0b013e32834f990f.
9
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.激素避孕与 HIV-1 传播风险:一项前瞻性队列研究。
Lancet Infect Dis. 2012 Jan;12(1):19-26. doi: 10.1016/S1473-3099(11)70247-X. Epub 2011 Oct 3.
10
Prevention of HIV-1 infection with early antiretroviral therapy.早期抗逆转录病毒疗法预防 HIV-1 感染。
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.

撒哈拉以南非洲的妇女与艾滋病病毒。

Women and HIV in Sub-Saharan Africa.

机构信息

HIV Prevention Research Unit, South African Medical Research Council, 123 Jan Hofmeyr Road, Westville, Durban 3629, South Africa.

出版信息

AIDS Res Ther. 2013 Dec 13;10(1):30. doi: 10.1186/1742-6405-10-30.

DOI:10.1186/1742-6405-10-30
PMID:24330537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3874682/
Abstract

Thirty years since the discovery of HIV, the HIV pandemic in sub-Saharan Africa accounts for more than two thirds of the world's HIV infections. Southern Africa remains the region most severely affected by the epidemic. Women continue to bear the brunt of the epidemic with young women infected almost ten years earlier compared to their male counterparts. Epidemiological evidence suggests unacceptably high HIV prevalence and incidence rates among women. A multitude of factors increase women's vulnerability to HIV acquisition, including, biological, behavioral, socioeconomic, cultural and structural risks. There is no magic bullet and behavior alone is unlikely to change the course of the epidemic. Considerable progress has been made in biomedical, behavioral and structural strategies for HIV prevention with attendant challenges of developing appropriate HIV prevention packages which take into consideration the socioeconomic and cultural context of women in society at large.

摘要

自发现 HIV 病毒 30 年来,撒哈拉以南非洲的 HIV 疫情占全球 HIV 感染人数的三分之二以上。南部非洲仍然是受该疫情影响最严重的地区。妇女继续首当其冲地受到疫情的冲击,年轻妇女比同龄男性早感染 HIV 病毒近十年。流行病学证据表明,该地区妇女的 HIV 流行率和发病率高得令人无法接受。许多因素增加了妇女感染 HIV 的脆弱性,包括生物学、行为、社会经济、文化和结构性风险。目前还没有灵丹妙药,单凭行为本身不太可能改变疫情的走向。在预防 HIV 的生物医学、行为和结构策略方面已经取得了相当大的进展,但随之而来的挑战是制定适当的 HIV 预防方案,这些方案需要考虑到整个社会中妇女的社会经济和文化背景。